These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
469 related items for PubMed ID: 9240741
21. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients. Chang HH, Asano N, Ishii S, Ichikawa Y, Fan JQ. FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036 [Abstract] [Full Text] [Related]
22. Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value. Boot RG, Hollak CE, Verhoek M, Sloof P, Poorthuis BJ, Kleijer WJ, Wevers RA, van Oers MH, Mannens MM, Aerts JM, van Weely S. Hum Mutat; 1997 Sep; 10(5):348-58. PubMed ID: 9375849 [Abstract] [Full Text] [Related]
23. Secretion of human glucocerebrosidase from stable transformed insect cells using native signal sequences. Sinclair G, Pfeifer TA, Grigliatti TA, Choy FY. Biochem Cell Biol; 2006 Apr; 84(2):148-56. PubMed ID: 16609695 [Abstract] [Full Text] [Related]
24. RecTL: a complex allele of the glucocerebrosidase gene associated with a mild clinical course of Gaucher disease. Zimran A, Horowitz M. Am J Med Genet; 1994 Mar 01; 50(1):74-8. PubMed ID: 8160756 [Abstract] [Full Text] [Related]
25. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease. van Weely S, van den Berg M, Barranger JA, Sa Miranda MC, Tager JM, Aerts JM. J Clin Invest; 1993 Mar 01; 91(3):1167-75. PubMed ID: 8450045 [Abstract] [Full Text] [Related]
26. Molecular analysis of Gaucher disease in a Vietnamese-Czechoslovak patient with high residual glucocerebrosidase activity. Choy FY, Woo M, Der Kaloustian VM. Am J Med Genet; 1991 Jun 15; 39(4):466-71. PubMed ID: 1877626 [Abstract] [Full Text] [Related]
27. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues. Choy FY. Am J Med Genet; 1985 Jul 15; 21(3):519-28. PubMed ID: 4025386 [Abstract] [Full Text] [Related]
28. Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations. Pomponio RJ, Cabrera-Salazar MA, Echeverri OY, Miller G, Barrera LA. Mol Genet Metab; 2005 Dec 15; 86(4):466-72. PubMed ID: 16185907 [Abstract] [Full Text] [Related]
29. Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations. Drugan C, Procopciuc L, Jebeleanu G, Grigorescu-Sido P, Dussau J, Poenaru L, Caillaud C. Eur J Hum Genet; 2002 Sep 15; 10(9):511-5. PubMed ID: 12173027 [Abstract] [Full Text] [Related]
30. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease. Chabás A, Gort L, Díaz-Font A, Montfort M, Santamaría R, Cidrás M, Grinberg D, Vilageliu L. Blood Cells Mol Dis; 2005 Sep 15; 35(2):253-8. PubMed ID: 15967693 [Abstract] [Full Text] [Related]
31. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene. Emre S, Gürakan F, Yüce A, Rolf A, Scott R, Ozen H. Eur J Med Genet; 2008 Sep 15; 51(4):315-21. PubMed ID: 18586596 [Abstract] [Full Text] [Related]
32. Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients. Amaral O, Marcão A, Sá Miranda M, Desnick RJ, Grace ME. Eur J Hum Genet; 2000 Feb 15; 8(2):95-102. PubMed ID: 10757640 [Abstract] [Full Text] [Related]
33. Gaucher disease: four families with previously undescribed mutations. Beutler E, Gelbart T, Balicki D, Demina A, Adusumalli J, Elsas L, Grinzaid KA, Gitzelmann R, Superti-Furga A, Kattamis C, Liou BB. Proc Assoc Am Physicians; 1996 May 15; 108(3):179-84. PubMed ID: 8774051 [Abstract] [Full Text] [Related]
34. Gaucher disease: complexity in a "simple" disorder. Sidransky E. Mol Genet Metab; 2004 May 15; 83(1-2):6-15. PubMed ID: 15464415 [Abstract] [Full Text] [Related]
35. Use of fluorescent substrates for characterization of Gaucher disease mutations. Ron I, Dagan A, Gatt S, Pasmanik-Chor M, Horowitz M. Blood Cells Mol Dis; 2005 May 15; 35(1):57-65. PubMed ID: 15916907 [Abstract] [Full Text] [Related]
36. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hruska KS, LaMarca ME, Scott CR, Sidransky E. Hum Mutat; 2008 May 15; 29(5):567-83. PubMed ID: 18338393 [Abstract] [Full Text] [Related]
37. Mutation analysis of 28 Gaucher disease patients: the Australasian experience. Lewis BD, Nelson PV, Robertson EF, Morris CP. Am J Med Genet; 1994 Jan 15; 49(2):218-23. PubMed ID: 8116672 [Abstract] [Full Text] [Related]
38. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients. Grabowski GA, Goldblatt J, Dinur T, Kruse J, Svennerholm L, Gatt S, Desnick RJ. Am J Med Genet; 1985 Jul 15; 21(3):529-49. PubMed ID: 3927728 [Abstract] [Full Text] [Related]
39. Glucocerebrosidase recombinant allele: molecular evolution of the glucocerebrosidase gene and pseudogene in primates. Wafaei JR, Choy FY. Blood Cells Mol Dis; 2005 Jul 15; 35(2):277-85. PubMed ID: 16102985 [Abstract] [Full Text] [Related]
40. Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease. Kim EY, Hong YB, Lai Z, Kim HJ, Cho YH, Brady RO, Jung SC. Biochem Biophys Res Commun; 2004 May 28; 318(2):381-90. PubMed ID: 15120612 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]